Asian Phytoceuticals Public Company Limited (APCO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Asian Phytoceuticals Public Company Limited (APCO) has a cash flow conversion efficiency ratio of 0.039x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (฿21.85 Million ≈ $681.11K USD) by net assets (฿560.19 Million ≈ $17.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Asian Phytoceuticals Public Company Limi net asset quality index to measure how much of total assets are equity-financed.
Asian Phytoceuticals Public Company Limited - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Asian Phytoceuticals Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check APCO cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Asian Phytoceuticals Public Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Asian Phytoceuticals Public Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Riverview Rubber Estates Bhd
KLSE:2542
|
0.009x |
|
Bingshan Refrigeration and Heat Transfer Technologies Co Ltd
SHE:200530
|
-0.003x |
|
Blackstone Minerals Ltd
AU:BSX
|
-0.023x |
|
Me2on Co. Ltd
KQ:201490
|
0.027x |
|
Marygold Companies Inc
NYSE MKT:MGLD
|
-0.040x |
|
Ildong Holdings Co Ltd
KO:000230
|
0.042x |
|
Usak Seramik Sanayi AS
IS:USAK
|
-0.004x |
|
VOC Energy Trust
NYSE:VOC
|
1.128x |
Annual Cash Flow Conversion Efficiency for Asian Phytoceuticals Public Company Limited (2007–2025)
The table below shows the annual cash flow conversion efficiency of Asian Phytoceuticals Public Company Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Asian Phytoceuticals Public Company Limi stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ฿560.19 Million ≈ $17.46 Million |
฿52.22 Million ≈ $1.63 Million |
0.093x | +38.53% |
| 2024-12-31 | ฿559.72 Million ≈ $17.45 Million |
฿37.67 Million ≈ $1.17 Million |
0.067x | -66.79% |
| 2023-12-31 | ฿612.39 Million ≈ $19.09 Million |
฿124.10 Million ≈ $3.87 Million |
0.203x | +23.49% |
| 2022-12-31 | ฿610.51 Million ≈ $19.03 Million |
฿100.18 Million ≈ $3.12 Million |
0.164x | +15.69% |
| 2021-12-31 | ฿594.99 Million ≈ $18.55 Million |
฿84.40 Million ≈ $2.63 Million |
0.142x | -2.64% |
| 2020-12-31 | ฿595.46 Million ≈ $18.56 Million |
฿86.75 Million ≈ $2.70 Million |
0.146x | +17.65% |
| 2019-12-31 | ฿579.19 Million ≈ $18.05 Million |
฿71.72 Million ≈ $2.24 Million |
0.124x | -12.82% |
| 2018-12-31 | ฿614.16 Million ≈ $19.14 Million |
฿87.24 Million ≈ $2.72 Million |
0.142x | -12.71% |
| 2017-12-31 | ฿628.31 Million ≈ $19.58 Million |
฿102.24 Million ≈ $3.19 Million |
0.163x | -15.31% |
| 2016-12-31 | ฿649.10 Million ≈ $20.23 Million |
฿124.71 Million ≈ $3.89 Million |
0.192x | -21.49% |
| 2015-12-31 | ฿568.18 Million ≈ $17.71 Million |
฿139.05 Million ≈ $4.33 Million |
0.245x | +20.92% |
| 2014-12-31 | ฿515.04 Million ≈ $16.05 Million |
฿104.25 Million ≈ $3.25 Million |
0.202x | -13.18% |
| 2013-12-31 | ฿404.28 Million ≈ $12.60 Million |
฿94.25 Million ≈ $2.94 Million |
0.233x | +19.99% |
| 2012-12-31 | ฿377.34 Million ≈ $11.76 Million |
฿73.32 Million ≈ $2.29 Million |
0.194x | +14.68% |
| 2011-12-31 | ฿371.61 Million ≈ $11.58 Million |
฿62.96 Million ≈ $1.96 Million |
0.169x | -23.41% |
| 2010-12-31 | ฿185.93 Million ≈ $5.80 Million |
฿41.13 Million ≈ $1.28 Million |
0.221x | +298.21% |
| 2007-12-31 | ฿121.73 Million ≈ $3.79 Million |
฿6.76 Million ≈ $210.77K |
0.056x | -- |
About Asian Phytoceuticals Public Company Limited
Asian Phytoceuticals Public Company Limited engages in the research and development, manufacture, and distribution of healthcare and natural extracts-based beauty products in Thailand. The company offers cream and lotion products in bottles and tubes for massage to tighten the skin and reduce the desired area, and facial lotion products; and products for reverse aging, anti-aging, and longevity. … Read more